3//SEC Filing
BAYER AKTIENGESELLSCHAFT 3
Accession 0001578563-23-000064
CIK 0001701478other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:16 PM ET
Size
10.0 KB
Accession
0001578563-23-000064
Insider Transaction Report
Form 3
Azitra IncAZTR
BAYER AKTIENGESELLSCHAFT
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (1,307,401 underlying)
Bayer US Holding LP
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (1,307,401 underlying)
BAYER HEALTHCARE LLC
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (1,307,401 underlying)
Bayer World Investments B.V.
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (1,307,401 underlying)
Footnotes (3)
- [F1]Each share of Series B Convertible Preferred Stock will automatically convert into one share of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date.
- [F2]The number of shares represented reflects a forward stock split at a ratio of 7.1-for-1 which was effectuated upon the effectiveness of the Issuer's Form S-1 (File No. 333-269876).
- [F3]The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.
Documents
Issuer
Azitra Inc
CIK 0001701478
Entity typeother
Related Parties
1- filerCIK 0001144145
Filing Metadata
- Form type
- 3
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:16 PM ET
- Size
- 10.0 KB